DK1370526T3 - Diamider som inhiberer tryptase og faktor Xa-virkning - Google Patents
Diamider som inhiberer tryptase og faktor Xa-virkningInfo
- Publication number
- DK1370526T3 DK1370526T3 DK02724182T DK02724182T DK1370526T3 DK 1370526 T3 DK1370526 T3 DK 1370526T3 DK 02724182 T DK02724182 T DK 02724182T DK 02724182 T DK02724182 T DK 02724182T DK 1370526 T3 DK1370526 T3 DK 1370526T3
- Authority
- DK
- Denmark
- Prior art keywords
- factor
- diamides
- action
- inhibit tryptase
- tryptase
- Prior art date
Links
- 108010074860 Factor Xa Proteins 0.000 title abstract 3
- 108060005989 Tryptase Proteins 0.000 title 1
- 102000001400 Tryptase Human genes 0.000 title 1
- 150000001470 diamides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000006806 disease prevention Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compounds Of Unknown Constitution (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01103662 | 2001-02-23 | ||
| EP01116782 | 2001-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1370526T3 true DK1370526T3 (da) | 2006-07-31 |
Family
ID=26076479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02724182T DK1370526T3 (da) | 2001-02-23 | 2002-02-22 | Diamider som inhiberer tryptase og faktor Xa-virkning |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7256194B2 (enExample) |
| EP (1) | EP1370526B1 (enExample) |
| JP (1) | JP2004523560A (enExample) |
| AT (1) | ATE327221T1 (enExample) |
| AU (1) | AU2002254907A1 (enExample) |
| CA (1) | CA2437114A1 (enExample) |
| CY (1) | CY1105506T1 (enExample) |
| DE (1) | DE60211665T2 (enExample) |
| DK (1) | DK1370526T3 (enExample) |
| ES (1) | ES2260428T3 (enExample) |
| PT (1) | PT1370526E (enExample) |
| WO (1) | WO2002068390A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0893437A4 (en) * | 1996-04-10 | 2000-12-27 | Ono Pharmaceutical Co | GUANIDINO TRYPTASE INHIBITOR |
| SI0921116T1 (en) * | 1997-12-04 | 2003-10-31 | F. Hoffmann - La Roche Ag | N-(4-carbamimido-phenyl)-glycine amide derivatives |
| DE19939910A1 (de) * | 1999-08-23 | 2001-03-01 | Morphochem Ag | Neue Verbindungen, die Tryptase-Aktivität hemmen |
| DE10041402A1 (de) * | 2000-08-23 | 2002-03-14 | Morphochem Ag | Neue Verbindungen, die Faktor Xa-Aktivität inhibieren |
-
2002
- 2002-02-22 DK DK02724182T patent/DK1370526T3/da active
- 2002-02-22 US US10/468,975 patent/US7256194B2/en not_active Expired - Fee Related
- 2002-02-22 ES ES02724182T patent/ES2260428T3/es not_active Expired - Lifetime
- 2002-02-22 PT PT02724182T patent/PT1370526E/pt unknown
- 2002-02-22 EP EP02724182A patent/EP1370526B1/en not_active Expired - Lifetime
- 2002-02-22 WO PCT/EP2002/001934 patent/WO2002068390A1/en not_active Ceased
- 2002-02-22 AU AU2002254907A patent/AU2002254907A1/en not_active Abandoned
- 2002-02-22 JP JP2002567904A patent/JP2004523560A/ja active Pending
- 2002-02-22 CA CA002437114A patent/CA2437114A1/en not_active Abandoned
- 2002-02-22 AT AT02724182T patent/ATE327221T1/de not_active IP Right Cessation
- 2002-02-22 DE DE60211665T patent/DE60211665T2/de not_active Expired - Lifetime
-
2006
- 2006-07-03 CY CY20061100900T patent/CY1105506T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1370526B1 (en) | 2006-05-24 |
| PT1370526E (pt) | 2006-08-31 |
| WO2002068390A8 (en) | 2002-10-31 |
| ES2260428T3 (es) | 2006-11-01 |
| DE60211665D1 (de) | 2006-06-29 |
| DE60211665T2 (de) | 2006-09-28 |
| WO2002068390A1 (en) | 2002-09-06 |
| CA2437114A1 (en) | 2002-09-06 |
| AU2002254907A1 (en) | 2002-09-12 |
| US7256194B2 (en) | 2007-08-14 |
| JP2004523560A (ja) | 2004-08-05 |
| US20040082547A1 (en) | 2004-04-29 |
| EP1370526A1 (en) | 2003-12-17 |
| ATE327221T1 (de) | 2006-06-15 |
| CY1105506T1 (el) | 2010-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004024375D1 (de) | Carboxamidderivate | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| GB0225475D0 (en) | Therapeutic agents | |
| IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
| MY132419A (en) | Inhibitors of factor xa and other serine proteases involved in the coagulation cascade | |
| MY135218A (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases | |
| GB0112348D0 (en) | Compounds | |
| UA83233C2 (ru) | Замещенный 2-аминотетралин для лечения депрессии | |
| TW200716574A (en) | The preparation and use of compounds as aspartyl protease inhibitors | |
| TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
| NO20053398L (no) | Farmasoytiske preparater av sertaconazol for vaginal anvendelse. | |
| HK1052170A1 (zh) | 新型化合物抑制因子xa活度 | |
| SE0101932D0 (sv) | Pharmaceutical combinations | |
| DK1206444T3 (da) | Forbindelser der hæmmer tryptaseaktivitet | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| MXPA04003611A (es) | Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
| SE0102440D0 (sv) | New compound | |
| AU7122501A (en) | Aryl sulfonamides as serotonin antagonist for the treatment of obesity | |
| ATE554764T1 (de) | Wirkungsvolle vereinfachte derivate von immunosuppressiva | |
| ATE377017T1 (de) | Verbindungen, die faktor xa-aktiv t inhibieren | |
| ATE295845T1 (de) | Prucaloprid-n-oxid | |
| AU2002254907A1 (en) | Diamides which inhibit tryptase and factor xa activity | |
| ATE447953T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis | |
| TW200730177A (en) | 4 anilino-3-quinolinecarbonitriles for the treatment of cancer |